A Medical Device Daily

PerkinElmer (Boston) reported the acquisition of a line of dynamic mechanical analysis (DMA) products from Triton Technology (Keyworth, UK) for an undisclosed sum.

The DMA instrument is used by scientists in the polymers, pharmaceuticals and food industries for diverse applications ranging from simple quality control to advanced research.

“This acquisition brings our customers a best-in-class thermal analysis tool that combines ease-of-use and flexibility with powerful performance,” said Robert Friel, president of PerkinElmer Life and Analytical Sciences.

“We believe that this transaction will allow our DMA technology to flourish in the very capable hands of PerkinElmer, while releasing resources within Triton Technology Ltd. allowing us to bring forward the development of radical new technology for the QA/QC of polymeric materials,” said Glynn Van-de-Velde, director, Triton Technology.

“Triton Technology will work very closely with PerkinElmer to ensure a smooth transition of the technology to the benefit of both existing and new customers alike.”

In other dealmaking news:

• Rosetta Biosoftware (Seattle) reported that Eisai (Tokyo) licensed the Elucidator system for differential protein expression analysis and biomarker discovery.

Eisai, one of the largest pharmaceutical companies in Japan, said it will be using the Elucidator system in its Laboratory of Seeds Finding Technology to support LC-MS quantification methods for identifying potential neurology biomarkers.

“The Elucidator system will be an important tool for enabling quantitative methods and characterizing cancer proteomes by multidimensional LC-MS/MS,” said Yoshiya Oda, PhD, senior scientist at the Laboratory of Seeds Finding Technology.

The Elucidator system’s data management capabilities are designed to allow users to effectively organize, search for, and retrieve raw and processed protein expression data. Rosetta Biosoftware is a provider of informatics solutions for life science research.

• ICV Capital Partners and Palladium Equity Partners reported that they have sold Hilsinger Holdings (Plainville, Massachusetts) to PNC Equity Partners (Pittsburgh). Terms of the transaction were not disclosed.

Hilsinger is a provider of eyewear and eye care accessory products and supplies in the U.S. and UK.